B cells as biomarkers: predicting immune checkpoint therapy adverse events.

Liudahl, Shannon M

B cells as biomarkers: predicting immune checkpoint therapy adverse events. [electronic resource] - The Journal of clinical investigation 02 2018 - 577-579 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Comment

1558-8238

10.1172/JCI99036 doi


Autoimmunity
B-Lymphocytes
Biomarkers
Humans
Immunotherapy
Programmed Cell Death 1 Receptor